Astellas Pharma Inc. ALPMY

Set alert

Price alert · ALPMY

All alert types
16.16 USD +0.16 +1.00%

At close · Oct 30

16.13 Day range 16.19
10.32 52-week range 17.35
YTD
+21.60%
1 year
+48.26%
Open
16.18
Prev close
16.00
Mkt cap
28.98B
Vol
6.47K
Avg vol
99.52K
EPS
1.32
P/E
12.24
More statistics
Low
16.13
High
16.19
Earnings
Oct 29, 2026

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ALPMY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.16 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 2
  • P/E 3
  • P/B 3

Valuation

P/E 14.9×
FY 2017: 14.2×FY 2018: 20.0×FY 2019: 14.8×FY 2020: 15.7×FY 2021: 26.3×FY 2022: 28.3×FY 2023: 34.7×FY 2024: 172×FY 2025: 51.1×FY 2026: 14.9×
FY 2017 5y median 34.7× FY 2026
P/S 2.0×
FY 2017: 2.4×FY 2018: 2.5×FY 2019: 2.5×FY 2020: 2.4×FY 2021: 2.5×FY 2022: 2.7×FY 2023: 2.3×FY 2024: 1.8×FY 2025: 1.4×FY 2026: 2.0×
FY 2017 5y median 2.0× FY 2026
P/B 2.5×
FY 2017: 2.4×FY 2018: 2.6×FY 2019: 2.6×FY 2020: 2.4×FY 2021: 2.3×FY 2022: 2.4×FY 2023: 2.3×FY 2024: 1.8×FY 2025: 1.7×FY 2026: 2.5×
FY 2017 5y median 2.3× FY 2026
P/FCF 8.6×
FY 2017: 16.4×FY 2018: 12.0×FY 2019: 15.7×FY 2020: 21.0×FY 2021: 13.8×FY 2022: 19.3×FY 2023: 14.1×FY 2024: 32.5×FY 2025: 19.0×FY 2026: 8.6×
FY 2017 5y median 19.0× FY 2026
EV/EBITDA 7.2×
FY 2017: 7.9×FY 2018: 10.4×FY 2019: 9.5×FY 2020: 10.0×FY 2021: 14.2×FY 2022: 14.1×FY 2023: 13.2×FY 2024: 18.0×FY 2025: 13.1×FY 2026: 7.2×
FY 2017 5y median 13.2× FY 2026
EV/Sales 2.0×
FY 2017: 2.1×FY 2018: 2.3×FY 2019: 2.3×FY 2020: 2.4×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 2.1×FY 2024: 2.2×FY 2025: 1.7×FY 2026: 2.0×
FY 2017 5y median 2.1× FY 2026
FCF Yield 11.7%
FY 2017: 6.1%FY 2018: 8.3%FY 2019: 6.4%FY 2020: 4.8%FY 2021: 7.3%FY 2022: 5.2%FY 2023: 7.1%FY 2024: 3.1%FY 2025: 5.3%FY 2026: 11.7%
FY 2017 5y median 5.3% FY 2026

Profitability

Gross Margin 74.6%
FY 2017: 72.8%FY 2018: 74.6%FY 2019: 74.9%FY 2020: 77.1%FY 2021: 78.4%FY 2022: 78.3%FY 2023: 78.5%FY 2024: 81.8%FY 2025: 81.7%FY 2026: 74.6%
FY 2017 5y median 78.5% FY 2026
Operating Margin 19.6%
FY 2017: 21.1%FY 2018: 20.9%FY 2019: 21.4%FY 2020: 21.5%FY 2021: 10.9%FY 2022: 12.0%FY 2023: 18.8%FY 2024: 1.6%FY 2025: 2.1%FY 2026: 19.6%
FY 2017 5y median 12.0% FY 2026
Net Margin 13.6%
FY 2017: 16.7%FY 2018: 12.7%FY 2019: 17.0%FY 2020: 15.0%FY 2021: 9.7%FY 2022: 9.6%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 2.7%FY 2026: 13.6%
FY 2017 5y median 6.5% FY 2026
ROE 16.8%
FY 2017: 17.2%FY 2018: 13.0%FY 2019: 17.7%FY 2020: 15.2%FY 2021: 8.7%FY 2022: 8.5%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 3.4%FY 2026: 16.8%
FY 2017 5y median 6.5% FY 2026
ROIC 13.2%
FY 2017: 15.2%FY 2018: 14.3%FY 2019: 17.9%FY 2020: 12.1%FY 2021: 6.2%FY 2022: 6.8%FY 2023: 11.7%FY 2024: 0.6%FY 2025: 1.6%FY 2026: 13.2%
FY 2017 5y median 6.8% FY 2026
ROA 8.6%
FY 2017: 12.1%FY 2018: 8.9%FY 2019: 11.7%FY 2020: 8.4%FY 2021: 5.3%FY 2022: 5.3%FY 2023: 4.0%FY 2024: 0.5%FY 2025: 1.5%FY 2026: 8.6%
FY 2017 5y median 4.0% FY 2026

Growth (YoY)

Revenue 18.6%
FY 2017: -4.4%FY 2018: -0.9%FY 2019: 0.5%FY 2020: -0.4%FY 2021: -3.9%FY 2022: 3.7%FY 2023: 17.2%FY 2024: 5.6%FY 2025: 19.2%FY 2026: 18.6%
FY 2017 FY 2026
Operating Income 984.4%
FY 2017: 2.2%FY 2018: -1.9%FY 2019: 3.3%FY 2020: -0.3%FY 2021: -51.3%FY 2022: 14.4%FY 2023: 83.3%FY 2024: -91.1%FY 2025: 60.8%FY 2026: 984.4%
FY 2017 FY 2026
EPS (diluted) 511.0%
FY 2017: 15.5%FY 2018: -21.8%FY 2019: 41.9%FY 2020: -9.4%FY 2021: -37.6%FY 2022: 3.3%FY 2023: -19.3%FY 2024: -82.5%FY 2025: 198.2%FY 2026: 511.0%
FY 2017 FY 2026
Free Cash Flow 293.1%
FY 2017: -5.0%FY 2018: 45.4%FY 2019: -23.7%FY 2020: -30.2%FY 2021: 57.6%FY 2022: -21.1%FY 2023: 34.2%FY 2024: -63.1%FY 2025: 52.5%FY 2026: 293.1%
FY 2017 FY 2026

Financial Health

Current Ratio 1.2×
FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.7×FY 2020: 1.1×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.4×FY 2024: 0.9×FY 2025: 1.1×FY 2026: 1.2×
FY 2017 5y median 1.2× FY 2026
Quick Ratio 0.9×
FY 2017: 1.7×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 0.7×FY 2025: 0.9×FY 2026: 0.9×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.1×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -0.1×
FY 2017: -1.0×FY 2018: -1.2×FY 2019: -1.0×FY 2020: 0.3×FY 2021: -0.2×FY 2022: -0.4×FY 2023: -0.7×FY 2024: 3.0×FY 2025: 2.6×FY 2026: -0.1×
FY 2017 5y median -0.1× FY 2026
Interest Coverage 29.8×
FY 2017: 207×FY 2018: 207×FY 2019: 215×FY 2020: 93.0×FY 2021: 58.3×FY 2022: 31.5×FY 2023: 32.5×FY 2024: 2.1×FY 2025: 2.3×FY 2026: 29.8×
FY 2017 5y median 29.8× FY 2026

Dividends

Dividend Yield 3.1%
FY 2017: 2.3%FY 2018: 2.2%FY 2019: 2.2%FY 2020: 2.4%FY 2021: 2.4%FY 2022: 2.4%FY 2023: 2.9%FY 2024: 4.0%FY 2025: 5.0%FY 2026: 3.1%
FY 2017 5y median 3.1% FY 2026
Payout Ratio 46.7%
FY 2017: 32.1%FY 2018: 43.5%FY 2019: 32.4%FY 2020: 37.6%FY 2021: 63.2%FY 2022: 68.7%FY 2023: 101.7%FY 2024: 684.4%FY 2025: 254.2%FY 2026: 46.7%
FY 2017 5y median 101.7% FY 2026

Annual · latest fiscal year ends 2026-03-31